Download FREE Report Sample
Download Free sampleAnti-emetic drugs are drugs that prevent or reduce nausea and vomiting. Antiemetic drugs inhibit vomiting reactions through different links, including thiazide drugs, antihistamines, and anticholinergics.
Anti-Emetic Drug Market contains market size and forecasts of Anti-Emetic Drug in global, including the following market information:
Global Anti-Emetic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Emetic Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Emetic Drug companies in 2021 (%)
The global Anti-Emetic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Emetic Drug include Merck, Novartis, Glenmark Pharmaceuticals, F. Hoffmann-La Roche, Heron Therapeutics, Kyowa Kirin, Aurobindo Pharma, Mylan and Hikma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Emetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Emetic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Emetic Drug Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Others
Global Anti-Emetic Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Emetic Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Others
Global Anti-Emetic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Emetic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Emetic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Emetic Drug revenues share in global market, 2021 (%)
Key companies Anti-Emetic Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-Emetic Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Glenmark Pharmaceuticals
F. Hoffmann-La Roche
Heron Therapeutics
Kyowa Kirin
Aurobindo Pharma
Mylan
Hikma
Akorn
Dr. Reddy?s Laboratories
Cipla
Fresenius Kabi
Wockhardt
Sun Pharmaceutical Industries
Teva Pharmaceutical
Pfizer
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy